Stocksigma LogoStocksigma Logo

Vaishali Pharma Board to Consider Preferential Issue and Capital Increase

Vaishali Pharma scheduled a Board meeting on 5th Nov'26 to evaluate raising funds via a preferential issue of equity shares

Vaishali Pharma Board to Consider Preferential Issue and Capital Increase

Vaishali Pharma Ltd 路 Intimation 路 03 Nov 2026, 2:58 am

Vaishali Pharma Board to Consider Preferential Issue and Capital Increase Vaishali Pharma scheduled a Board meeting on 5th Nov'26 to evaluate raising funds via a preferential issue of equity shares. The Board will also consider increasing authorized share capital from INR 27.00 Cr (13.50 Cr shares of INR 2 each) to INR 29.00 Cr (14.50 Cr shares of INR 2 each), appointing Rohil Sanjay Desai and Ketur Kishor Shah as Additional Independent Non-Executive Directors, and initiating a postal ballot to seek shareholder approval for these proposals.

Original exchange filing (PDF)

More announcements from Vaishali Pharma Ltd

All Vaishali Pharma Ltd announcements